[-] Show simple item record

dc.contributor.authorElliott, Margueriteeng
dc.contributor.authorCouchene, Elizabetheng
dc.contributor.authorLuft, Diane Daviseng
dc.date.issued2007-05eng
dc.description.abstractOnly high-risk close contacts of known cases should receive prophylactic antibiotics, according to the Centers for Disease Control and Prevention (CDC). The CDC defines high-risk as (1) infants who are <12 months, (2) those especially vulnerable to the complications of pertussis, or (3) those, such as health care workers, in close contact with high-risk individuals (strength of recommendation [SOR]: C, based on consensus/expert opinion). Evidence is insufficient to support a benefit of prophylactic antibiotic treatment for all household pertussis contacts to prevent the development or spread of illness (SOR: B, based on a systematic review of studies).eng
dc.identifier.citationJournal of Family Practice, 56(5) 2007: 399-400.eng
dc.identifier.urihttp://hdl.handle.net/10355/3687eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2007 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectantibioticseng
dc.subjecthigh-risk individualseng
dc.subjectinfantseng
dc.subject.lcshBordetella pertussis -- Preventioneng
dc.subject.lcshErythromycin -- Therapeutic useeng
dc.subject.lcshPertussis vaccineseng
dc.titleWhich patients with suspected exposure to pertussis should receive prophylaxis?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record